Pernix Therapeutics, Inc. (PTX) Completes Divesture of Non-Core Assets to Breckenridge Pharmaceutical, Inc.
9/12/2013 10:06:56 AM
HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it had completed the previously disclosed sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
Help employers find you! Check out all the jobs and post your resume.